Headquartered in Sweden, Bio-Works Technologies AB carries out R&D, manufacturing and supply of agarosebased resins used to separate proteins and other biomolecules. In this large and well-established area, the company’s products stand out as innovative and cutting edge with exceptional performance. They are used in academic research laboratories, biopharmaceutical companies and many more areas. Amidst the pandemic, the company announced the appointment of Jonathan Royce as the new Chief Executive Officer (CEO). Royce has a background in senior leadership roles within large-scale suppliers to the biopharmaceutical market including MerckMillipore and GE Healthcare Life Sciences (now Cytiva). BioSpectrum interacted with Jonathan Royce to find out what Bio-Works has in store for the Indian market. Edited excerpts;
What were the key highlights at Bio-Works in 2020?
2020 was a year in which Bio-Works expanded its global reach in several key markets. We established a US-subsidiary and hired two sales managers in the US market (one in Boston, one in San Diego) and substantially grew our business in key Asian markets, most notably South Korea. We brought on Dr Ravi Rayanade in India as a Director Regional Sales to better be able to serve our growing base of customers in the Indian biotech market. And we added new distributors in India (Arihant and BioLinx) and Taiwan (Yong Chien Technology). Also during the past year, Bio-Works continued its quality improvements with a successful re-certification against the ISO 9001:2015 quality standard. This certification ensures that Bio-Works resins meet the strict requirements of users, who are producing biopharmaceuticals under Good Manufacturing Practices (GMP). We also concluded a number of studies designed to strengthen the data offered to users in our Regulatory Support Files.
What are the major plans for 2021?
Continue reading your story on the app
Continue reading your story in the magazine
Rare diseases policy outlines challenges sans solutions
There is no substantial data on the number of people suffering from rare diseases in India and the data that is available is from tertiary care hospitals. The lack of epidemiological data on rare diseases makes it a herculean task to determine the prevalence and burden of rare diseases, hence hampering the definition of rare diseases in the Indian context.
PSA launches community mental-health digital platform
The Principal Scientific Adviser (PSA) to the Government of India Prof. K VijayRaghavan has virtually launched ‘MANAS’ App to promote wellbeing across age groups.
“India should have a vibrant clinical research community who can advise drug developers”
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the appointment of Dr Sanish Davis as its President for the term 202123.
MALARIA DENGUE TB PLAY SECOND FIDDLE to COVID - 19
Although India has worked relentlessly towards developing innovative testing solutions for COVID-19 throughout last year, the timely detection of a number of other infectious diseases has been sidelined. In India, the range and burden of infectious diseases such as tuberculosis, malaria, filariasis, leprosy, HIV infection, typhoid, hepatitis etc., are enormous. In fact, inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of chikungunya virus disease and typhus fever. If India can develop more than 20 different diagnostic tests or devices in a single year to fight COVID-19, many more such innovations can be brought to effectively detect other infections looming in our country.
Govt fast-tracks emergency approvals for foreign-made COVID-19 vaccines
The matter of augmenting the basket of vaccines available for fighting the pandemic as well as accelerating the pace and coverage of domestic vaccination programmes was discussed recently at the 23rd meeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
Wipro Focuses On Transforming Vaccine Safety Assessment
Bengaluru -based IT firm Wipro has announced a partnership with Hyderabad-based Transcell Oncologics to transform vaccine safety assessment using augmented intelligence (AI).
Dr. Reddy's Launches Sputnik V Vaccine In India
Dr. Reddy’s Laboratories announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021. As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad on May 14, 2021.
“Made in India products need an ecosystem for commercialisation of innovations”
Established in 1998, Ernakulam-based Agappe Diagnostics is one of the rapidly growing companies in the in vitro diagnostic (IVD) industry in India, having a wide range of products in the pre-analytical and analytical segment. Focused on research, design, and production of clinical chemistry reagents and instrument, Agappe has over 1000 distributors and holds a significant place in the global original equipment manufacturer (OEM) business. The company currently has a workforce of more than 600 employees spread across sectors such as R&D, manufacturing, sales, support and operations. In conversation with BioSpectrum, Thomas John, Managing Director, Agappe Diagnostics, Ernakulam shares his strategies and plans for the company’s growth in the long run.
Vocalising pain is a must
Women have unique health issues. In fact, some of the health issues that affect both men and women can affect women very differently.
“India should focus on innovating drugs and molecules to emerge as a global leader”
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President for a period of two years, effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is currently serving as the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. He is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently. In conversation with BioSpectrum, S Sridhar talks about making a difference to patients, the industry and the country via this new role.
Sometimes, an idea needs time to incubate until it’s ready to grow. That was the case with Sujata Massey’s series about Perveen Mistry, a woman attorney practicing in India during the 1920s.
THIRTEEN FASCINATING 4X4S from the2020 Fall 4-Wheel Jamboree Nationals
Recap of the 39th Annual O’Reilly Auto Parts Fall 4-Wheel Jamboree Nationals
Klara Landrat & Her Journey with Endometriosis
Klara Landrat is an American-Israeli actress of Polish origin, producer, a writer known for her talent worldwide. She is starring in the Irish TV series – “Gods & Fighting Men” due for release in 2021.
HER MAJESTY PEDDLING HOMEMADE HOOCH!
QUEEN ELIZABETH looks like a dowdy, straitlaced granny, but she’s turned into a heck of a bartender — serving up her own brands of homemade hooch!
The Winter of Discontent
Even though america is preparing for a summer reopening, the Coronavirus will still be around to dog us when the temperatures fall.
India thought it had the virus beat. The virus had other ideas
Governments around the world keep repeating the same mistakes. In a country of 1.4 billion, the consequences are on a whole new scale
Reincarnation And Realpolitik
China, India, and the U.S. are vying to influence the selection of the next Dalai Lama
An Exclusive Interview With Nandakumar Narasimhan
The Little Red Train
A Room for Dad
Before Mom passed, I made a promise to her